Clinical Use of Stem Cells for the Treatment of Covid-19

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

November 30, 2020

Conditions
Covid19PneumoniaMultiple Organ FailureCorona Virus Infection
Interventions
BIOLOGICAL

MSC Treatment

"Protocol length: 1 week~Doses:~1. Application: 3 million cells/kg IV-------------------------------------------------0 day~2. Application: 3 million cells/kg IV ------------------------------------------------3rd day~3. Application: 3 million cells/kg IV -------------------------------------------------6th day~will be given to patients positively, clinically and radiologically diagnosed with COVID-19, followed with 3 months observation."

BIOLOGICAL

Saline Control

Saline will be given to patients positively, clinically and radiologically diagnosed with COVID-19, followed with 3 months observation.

Trial Locations (2)

34010

Istinye University, Istanbul

34147

SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Istanbul

All Listed Sponsors
collaborator

Istinye University

OTHER

collaborator

Regenerative Medicine and Stem Cell Production Center Liv MedCell

UNKNOWN

collaborator

Liv Hospital (Ulus)

UNKNOWN

lead

SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi

OTHER

NCT04392778 - Clinical Use of Stem Cells for the Treatment of Covid-19 | Biotech Hunter | Biotech Hunter